Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Hospital Medicine (London, England : 1998)|September 6, 2002
Benign prostatic hyperplasia: solutions to an ageing problemCharlotte L Foley, Simon R J Bott, Manit Arya, et al.Drugs of Today (Barcelona, Spain : 1998)|May 19, 2004
An update on the use of 5alpha-reductase inhibitorsCharlotte L Foley, Simon R J Bott, Iqbal S Shergill, et al.BJU International|January 11, 2005
Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over timeSimon R J Bott, A Alex Freeman, Sally Stenning, et al.Annals of Vascular Surgery|May 29, 2007
Intraoperative flow measurements are helpful in the treatment of high-inflow steal syndrome on a predialysis patient with a brachiocephalic fistula: a case reportEric S Chemla, Vincent C Y Tang, Susan A EymanBJU International|June 18, 2010
The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancerSimon R J Bott, Hashim U Ahmed, Richard G Hindley, et al.Annals of the Royal College of Surgeons of England|March 8, 2008
Ureteric stent card register - a 5-year retrospective analysisVincent C Y Tang, John Gillooly, Elaine W Y Lee, et al.Urology|November 11, 2006
Extensive transperineal template biopsies of prostate: modified technique and resultsSimon R J Bott, Alastair Henderson, James E Halls, et al.BJU International|August 23, 2011
The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillanceBenjamin E Ayres, Bruce S I Montgomery, Neil J Barber, et al.BJU International|February 28, 2007
Are prostatic biopsies necessary in men aged > or =80 years?Simon R J Bott, Charlotte L Foley, Matthew D Bull, et al.European Radiology|May 20, 2017
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trialFrancesco Giganti, Caroline M Moore, Nicola L Robertson, et al.Pageof 2